Objective: Complex Crawford extent II thoracoabdominal aortic aneurysms (TAAAs) can be treated in a hybrid manner with proximal thoracic endovascular aneurysm repair, followed by staged distal open thoracoabdominal repair. This study evaluated the outcomes and health care-associated value of this new method compared with traditional open repair over 10 years.
Thoracoabdominal aortic aneurysms (TAAAs) have a dismal, progressive course, with an inflection point at 7 cm where >40% will rupture. [1] [2] [3] Because no effective medical therapy currently exists, standard treatment involves open surgical replacement of the aneurysmal aorta. The Crawford classification categorizes TAAAs, where extent II involves the longest length of aorta from the left subclavian artery to the aortoiliac bifurcation. Repair of extent II aneurysms typically involves replacement of the descending and abdominal aorta to the bifurcation. Because these repairs are the most extensive performed for aortic aneurysms, they are associated with the highest complication rates. [3] [4] [5] [6] [7] [8] Extent II aneurysm repair has incrementally evolved, and protocols currently emphasize multimodal organ protection. 3, [9] [10] [11] This includes permissive hypothermia, circulatory support with selective renal and visceral perfusion, cerebrospinal fluid drainage, and aggressive reimplantation of segmental arteries. Newer evidence suggests that staged hybrid repair can supplement these techniques to further reduce morbidity. [12] [13] [14] [15] [16] [17] [18] The results suggest that thoracic endovascular aortic repair (TEVAR), followed by open distal repair, is a safe and reasonable repair strategy. However, evidence regarding outcomes compared with open repair is limited. In addition, staged hybrid repair requires multiple procedures that are likely to attract critique in an era of value-based care models. New technology is associated with high development costs, and these charges will require justification with improved outcomes. The concept of health care-related value was most eloquently promoted by Porter and Teisberg, 19 where they describe restructuring our health system to maximize health outcomes per dollar spent. Critical to this idea is shifting from a provider-and volume-based analysis of outcomes to a patient-centered analysis of efficiency. 20, 21 This idea is separate from cost-effectiveness analyses and instead encompasses quality, efficiency, costs, and complications. The result is a simple metric: a ratio of outcomes to cost. This idea is being translated into alternative payment models that reward value, with Centers for Medicare and Medicaid Services aiming to have 50% of alternative based payments related to value and quality by 2018. 22 With such a focus on value, it is surprising to note the dearth of value-related research in surgery. 23 The purpose of the present study was to compare morbidity, mortality, cost, and value for staged hybrid vs open repair of extent II TAAAs. We hypothesized that patients will have improved outcomes with the staged hybrid approach but that this new technology will be associated with increase health care costs, resulting in similar value for the care of these complex patients.
METHODS
Study population. were performed with SAS 9.4 software (SAS Institute, Inc, Cary, NC). Table I , with no statistically significant differences identified. The mean creatinine value before open repair was higher for the staged hybrid cohort, but this did not reach statistical significance (1.3 mg/dL vs 1.1 mg/dL; P ¼ .24). The median time between TEVAR and open repair in the staged hybrid group was 129 days (interquartile range, 55-396 days).
RESULTS
Procedural outcomes. The TEVAR procedure methods and results are reported in Table II . Endoleaks were identified in nine patients, five of whom required reintervention for type Ia endoleaks. Renal failure developed in one patient with a history of stage III chronic kidney disease. Almost 50% of patients required a carotidsubclavian bypass, with a median time from bypass to TEVAR of 2 days. Overall, the median length of stay was 6 days, and median days before the staged open repair was 129.
Operative characteristics for open TAAA repair (excluding TEVAR) did differ between hybrid and standard open patients, as summarized in Table III . The surgical component of hybrid cases involved more frequent use of cerebrospinal fluid drainage, left heart bypass, and selective visceral and renal perfusion. Despite the increased adjunctive techniques, mean operative time was lower (256 minutes vs 306 minutes; P ¼ .01).
There was no statistical difference in in-hospital mortality (4.0% vs 3.4%; P ¼ .89), also reported in Table III . The rate of AKI was higher in the hybrid cohort (76% vs 51%; P ¼ .03), but AKI resolved in 89% of hybrid patients and in 91% of standard open repair patients (P ¼ .84). Consequently, the difference in the rate of renal failure requiring dialysis was not significant (8% vs 4.5%; P ¼ .84). The composite measure of death, spinal cord ischemia, and renal failure was significantly lower in the hybrid repair cohort (20% vs 49%; P ¼ .01). The median length of stay after open repair was significantly lower for the hybrid patients (10 days vs 13 days; P ¼ .04).
Cost and value. Detailed cost and charge data are summarized in Table IV Total physician charges were significantly higher in the staged hybrid group ($72,021 vs 23,570; P < .0001) because of the additional charges during TEVAR (Table IV) . However, the physician charges for the TAAA open repair were not significantly different ($33,913 vs $23,570; P ¼ .11). Analysis using the standard open procedure as the benchmark for value showed the staged hybrid procedure had increased value (Table V) . The value was increased by 56% when median hospital cost was used and by 78% when mean costs were used.
DISCUSSION
Repair of extent II TAAAs is associated with a high rate of morbidity, with an overall 42% rate of composite MAEs in this single-center experience. However, the MAE rate for staged hybrid repair was significantly lower than the standard open rate, at 20% compared with 49%. Staged hybrid TAAA repair was associated with a significantly lower rate of spinal cord ischemia. AKI rates were higher in the hybrid repair cohort, but the high rate of recovery resulted in no difference in the rate of renal failure requiring dialysis. The median total cost was significantly higher in the staged hybrid cohort, at $113,000 compared with $72,000 for the standard open repair. Considering MAEs and cost together, staged hybrid repair represents better value by >58% compared with the standard open repair technique.
Spinal cord ischemia can be a life-altering complication that occurs with unfortunately high frequency after extent II TAAA repair, ranging from 7% to >30%.
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The rates of spinal cord ischemia demonstrated in this analysis are consistent with the literature and were significantly lower in the group undergoing staged hybrid repair, at 8% compared with 19% in the standard open repair cohort. The hybrid repair methodology effectively converts an extent II TAAA into an extent III/IV TAAA. These less extensive aneurysm repairs are associated with much lower rates of spinal cord ischemia. 7, 26 In addition, Etz et al 27 previously demonstrated that staged open procedures, first thoracic aneurysm repair, followed by distal abdominal repair, were associated with a decreased rate of spinal cord injury, from 17% to 0%. Our results demonstrate that this outcome can be replicated using TEVAR. An additional benefit may come from temporary aneurysm sac perfusion associated with type Ib endoleaks partially perfusing the spinal cord until the open surgery. 28 Although the reduction seen with staged hybrid repair is confounded by a higher rate of lumbar drain use, this likely does not account for the 50% reduction in MAEs. Renal failure after standard open repair of extent II TAAA is 16% to 26% in contemporary series. 5, 7, 29 The rate of AKI after TEVAR varies with the complexity of the lesion and definition of kidney injury but has been reported to be between 17% and 23%. 30, 31 Therefore, the increased AKI in our staged hybrid group is not surprising because these patients are undergoing a previous procedure that causes renal insult in one-fifth of all patients. Despite a median interval of 129 days between TEVAR and open distal repair, they still experienced increased frequency of AKI. Other limited reports of staged hybrid repair indicate similar renal failure rates as reported in this single-center study. 18 Despite higher rates of AKI, a detailed analysis reveals a low incidence of progression to renal failure. These results suggest selective renal perfusion is effective and that staged hybrid repair does not increase the risk for renal failure.
The resource utilization associated with the TEVAR component of the hybrid repair is not trivial and is in fact higher than isolated TEVAR. 32 23, 24 This metric allows a reasonable assessment of short-term outcomes in relation to cost. The major complications associated with TAAA repair include renal failure, spinal cord ischemia, and death. A composite of these measures is a reasonable assessment of MAEs. Using this metric, we demonstrate that despite increased cost, the staged hybrid repair represents reasonable value. The decreased rate of MAEs more than compensates for the increased hospital costs, resulting in an increase in value of between 56% and 78%. This variability is due to high cost outliers associated with standard open repair, as demonstrated in the box-and-whisker plot (Fig). The median costs represent a conservative estimate of value at 156% for hybrid repair. However, to better account for the high-cost outliers, the mean costs demonstrate an even larger value increase at 178%. The outliers are likely due to open repair being associated not only with an increased complication rate but also increased complication severity.
This study is limited by the single-center, retrospective nature of the analysis with a potential for selection bias. Baseline characteristics were mostly similar, but a higher percentage of hybrid repair patients had prior aortic dissection. In addition, surgical practices changed over time, and this is apparent and clearly explained in the operative characteristics. There may also be dropout Finally, value would ideally be assessed in a riskadjusted manner such as has been previously done in the cardiothoracic surgery literature. 24 Unfortunately, robust risk models are not available, although baseline assessment of patients demonstrated similar comorbidities and risk factors.
Although not available for analysis in this cohort, entirely endovascular TAAA repair represents another opportunity to assess the value of technologic innovation. Current spinal cord ischemia rates are high, but as the technology advances and adjuncts, such as temporary aneurysm sac perfusion, help decrease this rate, its value should be assessed. 28 
CONCLUSIONS
The 20% MAE rate associated with staged hybrid repair of extent II TAAA was significantly decreased compared with open TAAA repair, with a relative reduction of >50%. Despite higher total hospital costs, staged hybrid repair had 56% to 78% higher health care-related value compared with standard open repair. In an era of increasing focus on costs as well as quality, staged hybrid repair of extensive aortic aneurysms is associated with fewer complications than open repair, resulting in a good value investment from a resource utilization perspective.
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